Futura Medical (LON:FUM) Stock Price Down 9.7% – What’s Next?

Futura Medical plc (LON:FUM)’s stock price fell 9.7% on Tuesday . The stock traded as low as GBX 0.24 and last traded at GBX 0.50. Approximately 7,041,876 shares changed hands during trading, a decline of 18% from the average daily volume of 8,535,829 shares. The stock had previously closed at GBX 0.55.

Futura Medical Stock Performance

The firm’s 50 day moving average price is GBX 0.65 and its 200-day moving average price is GBX 1.03. The company has a market cap of £2.33 million, a P/E ratio of -0.14 and a beta of 0.02.

Futura Medical (LON:FUM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. The business had revenue of GBX 170 million during the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. Analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.